PARP inhibitors in prostate cancer: time to narrow patient selection?

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)1-4
Number of pages4
JournalExpert Review of Anticancer Therapy
DOIs
StatePublished - 2020

Keywords

  • PARP inhibitors
  • metastatic castration-resistant prostate cancer
  • niraparib
  • olaparib
  • prostate cancer
  • rucaparib
  • talazoparib

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this